We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 23, 2021

Veliparib Monotherapy Following Carboplatin/Paclitaxel Plus Veliparib Combination Therapy in Patients With Germline BRCA-Associated Advanced Breast Cancer

Annals of Oncology

 

Additional Info

Annals of Oncology
Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trial
Ann. Oncol 2021 Nov 30;[EPub Ahead of Print], HS Han, BK Arun, B Kaufman, H Wildiers, M Friedlander, JP Ayoub, SL Puhalla, BA Bach, MG Kundu, N Khandelwal, D Feng, S Bhattacharya, D Maag, CK Ratajczak, V Diéras

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading